 |
Video: What is a Stock Split?
|
 |
Medgenics is a clinical stage biopharmaceutical company with an emphasis on Genomic Medicine. Co. has rights to develop NFC-1, a non-stimulant metabotropic glutamate receptor (mGluR) neuromodulator for the treatment of mGluR network mutation positive Attention Deficit Hyperactivity Disorder, as well as neuropsychiatric symptoms resulting from a related rare genetic disorder, 22q11.2 Deletion Syndrome. Co. is also developing its Transduced Autologous Restorative Gene Therapy, a protein therapy that uses the patient's own skin to provide sustained production and delivery of therapeutic protein. Co. has developed the DermaVac, a proprietary harvesting device. According to our MDGN split history records, MDGN has had 2 splits. | |
 |

MDGN (MDGN) has 2 splits in our MDGN split history database. The first split for MDGN took place on February 03, 2003. This was a 1 for 80 reverse split, meaning for each 80 shares of MDGN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 12.5 share position following the split. MDGN's second split took place on November 18, 2003. This was a 4 for 1 split, meaning for each share of MDGN owned pre-split, the shareholder now owned 4 shares. For example, a 12.5 share position pre-split, became a 50 share position following the split.
When a company such as MDGN splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as MDGN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the MDGN split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into MDGN shares, starting with a $10,000 purchase of MDGN, presented on a split-history-adjusted basis factoring in the complete MDGN split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/01/2013 |
|
End date: |
12/15/2016 |
|
Start price/share: |
$7.62 |
|
End price/share: |
$5.57 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-26.90% |
|
Average Annual Total Return: |
-9.31% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,308.72 |
|
Years: |
3.21 |
|
|
 |
Date |
Ratio |
02/03/2003 | 1 for 80 | 11/18/2003 | 4 for 1 |
|
 |